A Study of Erdafitinib Versus Investigator Choice of Intravesical Chemotherapy in Participants Who Received Bacillus Calmette-Guérin (BCG) and Recurred With High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Washington University School of Medicine
University of Southern California
National Institutes of Health Clinical Center (CC)
Bruckner Oncology
University of Florida
Albert Einstein College of Medicine
Radiation Therapy Oncology Group
M.D. Anderson Cancer Center
University of Cincinnati
Eastern Cooperative Oncology Group
Mayo Clinic
M.D. Anderson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Wake Forest University Health Sciences
University of Michigan Rogel Cancer Center